Pharma Mar (UK) Today
| 0RC6 Stock | 72.55 2.34 3.12% |
Performance19 of 100
| Odds Of DistressLess than 27
|
Pharma Mar is selling for under 72.55 as of the 22nd of November 2024; that is 3.12 percent down since the beginning of the trading day. The stock's lowest day price was 60.24. Pharma Mar has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Pharma Mar SAU are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Moving against Pharma Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharma Mar's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharma Mar or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive ViceChairman | Pedro Puentes |
| Business Concentration | Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) |
Pharma Mar SAU (0RC6) is traded on London Exchange in UK and employs 509 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharma Mar's market, we take the total number of its shares issued and multiply it by Pharma Mar's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharma Mar SAU operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 221.28 M outstanding shares.
Pharma Mar generates negative cash flow from operations
Check Pharma Mar Probability Of Bankruptcy
Ownership AllocationPharma Mar owns a total of 221.28 Million outstanding shares. Pharma Mar has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharma Ownership Details
Pharma Mar SAU Risk Profiles
Although Pharma Mar's alpha and beta are two of the key measurements used to evaluate Pharma Mar's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.18 | |||
| Semi Deviation | 1.54 | |||
| Standard Deviation | 3.77 | |||
| Variance | 14.22 |
Pharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharma Mar without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Pharma Mar Corporate Directors
| Elena Crespo | Director Admin | Profile | |
| Jos MartinezLosa | Director Relations | Profile | |
| Juan Nogues | Director Sales | Profile | |
| Luis Cuenca | Director IT | Profile |
Additional Tools for Pharma Stock Analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.